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E-mail address: deborah.henderson@ncl.ac.uk (D.JThe cardiovascular system consists of many cell types with distinct embryonic origins. Cells from an
Islet1 (Isl1)-expressing progenitor population make a substantial contribution to the developing
heart.We reasoned that cells derived from Isl1-expressing progenitorsmight contributemorewidely
to the cardiovascular system. We show that cells derived from an Isl1-expressing progenitor lineage
make a wide contribution to the systemic vasculature and that embryos conditionally deﬁcient for
Rac1 within this cell population develop defects in the non-cardiac vasculature. These data deﬁne
new roles for Isl1 in the developing embryo and demonstrate a contribution of Isl1-expressing
progenitors to vascular endothelium in vivo.
Crown Copyright  2012 Published by Elsevier B.V. on behalf of Federation of European Biochemical
society. All rights reserved.1. Introduction within Isl1-expressing progenitors developed umbilical haemor-Isl1is a LIM-homeodomain transcription factor that is expressed
in motor neurons, dorsal root ganglia and sympathetic ganglia.
Isl1-expressing cells are also found in the pharyngeal region of
the early embryo and identify the second heart ﬁeld. The second
heart ﬁeld adds to the primary heart tube, giving rise to the myo-
cardium of the outﬂow tract, right ventricle and atria, and the
smooth muscle cells of the distal outﬂow and inﬂow tracts [1,2].
Contributions to the endocardium of the heart are more controver-
sial, but cells from an Isl1-expressing lineage appear to form at
least some of the endocardium of the outﬂow region [1,3]. Once
these second heart ﬁeld cells differentiate, the expression of Isl1
is down regulated [1]. Thus, Isl1 has become an important marker
for the second heart lineage, and Isl1Cre, an important driver line
for analysis of the biology of this cell population.
Although Isl1-expressing embryonic stem cells have been shown
to be capable of forming endothelial cells in vitro [4,5], contribu-
tions to the vasculature outside of the heart have not been reported
in vivo. We used Isl1Cre based lineage tracing and immunohisto-
chemical analysis to show that Isl1Cre-expressing cells are more
widely distributed in the cardiovascular system than previously de-
scribed.We show that cells derived from an Isl1-expressing progen-
itor lineage contribute to the endothelium of the aorta, the cardinal
veins (that later contribute to the formation of the jugular and caval
veins), and are also found in the umbilical vessels and their inter-
face with the placenta. Embryos with Rac1 conditionally deletedd by Elsevier B.V. on behalf of Fede
. Henderson).rhage and defects in the separation of the blood and lymphatic sys-
tems. These data provide crucial in vivo support for the previous
in vitro studies suggesting that Isl1-expressing precursors can give
rise to endothelial derivatives. Moreover, this has important impli-
cations for the interpretation of other studies in which the Isl1Cre
line has been used for conditional knock out studies.
2. Materials and methods
2.1. Mouse strains and embryo collection
Isl1Cre [6], Mef2C-AHFCre [7], ROSA26R [8], ROSA-EYFP [9] and
Rac1ﬂox [10] mouse lines were used to generate embryos for
analysis. Mice were managed according to the Animals (Scientiﬁc
Procedures) Act 1986 of the UK Government. Male and female mice
were mated overnight to generate timed pregnancies. The middle
of the day in which a copulation plug had been identiﬁed that
morning was designated E0.5. Embryos were dissected, ﬁxed, and
prepared either for X-gal staining, embedding in parafﬁn wax, or
for cryo-embedding. At least three embryos of each genotype were
examined at each gestational age. Whole embryo images were
captured using a Leica MZ 12.5 microscope and Leica imaging
software.
2.2. b-Galactosidase staining of Isl1Cre/ROSA26R embryos
b-Galactosidase staining was performed according to standard
protocols [11,12]. Isl1Cre;ROSA26R embryos and extra-embryonicration of European Biochemical society. All rights reserved.
Fig. 1. Cells from an Isl1+ lineage are found in the systemic vasculature. In (A,B) Isl1Cre is marked by b-gal staining. In (C,E-G) Isl1Cre is brown and in D Isl1Cre is green
ﬂuorescent. Arrows point to Isl1Cre-labelled cells. (A) Cells labelled by Isl1Cre are seen in stripes extending towards the posterior part of the embryo at E8.5. (B,C) At E9.5 and
E11.5, Isl1Cre-expressing cells are found in the endothelium of the dorsal aorta (ao) and cardinal vein (cv). (D) Isl1Cre-expressing cells co-express VE-cadherin (double-labeled
cells are yellow; see arrows). (E) Isl1Cre labeled cells are found in the endothelium of the aorta at the level of the hindgut. (F,G) At E15.5, Isl1Cre expressing cells are found in
the endothelium of the descending aorta and caval veins (cavv) (F) and throughout the endothelium of the ascending aorta, pulmonary trunk (pt) and ductus arteriosus (da)
(G). (H,I) The endothelium of the aorta and cardinal veins is not labeled by an antibody raised against Isl1 protein, although positive cells are found within forming ganglia (g).
Scale bar: A = 300 lm; B,C,H = 50 lm, D = 30 lm, E,F,I = 100 lm, G = 400 lm.
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transferred to ﬁxation solution (0.1 M phosphate buffer, 2% parafor-
maldehyde, 5 mM EGTA, 0.2% glutaraldehyde and 2 mM MgCl2) at
4 C. E8.5–E9.5, E10.5–E12.5 and E13.5–E15.5 embryos were ﬁxed
for 5, 15 and 20 min, respectively. The heads and tails were re-
moved from embryos of E11.5–E15.5, and staining solution was al-
lowed to penetrate the embryo by puncturing of the left ventricle.
Following ﬁxation, embryos were washed in a buffer containing
0.1 M phosphate buffer, 0.01% Na-deoxycholate, 0.02% Nonidet-
P40 and 2 mM MgCl2 at room temperature in accordance with the
times appropriate to each stage, as described above. After washing,
the embryos were stained in the dark overnight at 37 C in staining
solution (wash buffer containing 1 mg/ml X-gal in dimethyl form-
amide, 10 mM K-ferricyanide, and 10 mM K-ferrocyanide). Wash
buffer was used to remove stain and ﬁxation was performed for
24 h (E8.5–E10.5) or 48 h (E11.5–E15.5) as appropriate at 4 C in
4% paraformaldehyde. Embryos were then embedded in parafﬁn
wax and sectioned. 1% aqueous eosin solution was used for count-
erstaining sections. Penetration of the heart in wholemount stained
samples was conﬁrmed by X-gal staining of Wnt1-Cre;ROSA26R fe-
tuses that had been cryoembedded and sectioned. For each stage
of gestation, a minimum of three embryos were studied.
2.3. Immunohistochemistry
Immunohistochemistry was performed on parafﬁn wax sec-
tions according to standard protocols [11]. Embryos were dissectedin ice-cold 1% phosphate buffered saline and ﬁxed in 4% parafor-
maldehyde at 4 C for a length of time appropriate to gestational
age (overnight for E8.5–E11.5 and 48 h for E12.5–E15.5). Ten
micrometer tissue sections were cut and Histoclear (National Diag-
nostics) was used for dewaxing. Sections were then hydrated
through an ethanol gradient and treated with 0.6% H2O2. A 10%
solution of fetal bovine serum (Sigma) was used for the blocking
of sections. Primary antibodies, including anti-GFP (Abcam) and
anti-Isl1 (Developmental Hybridoma Studies Bank), were diluted
in 2% fetal bovine serum and incubated with the sections, over-
night at 4 C. Sections were then incubated at room temperature
for 1 h with either secondary anti-chicken IgY antibody conjugated
to biotin (Abcam) or anti-mouse antibody conjugated to biotin
(Dako) diluted in 2% fetal bovine serum. Avidin–biotin complex
conjugated to horseradish peroxidase (Dako) treatment, and diam-
inobenzidine (Sigma) staining, was used to visualise immunoreac-
tivity. Counterstaining of sections was performed in 0.5% aqueous
methyl green solution and Histomount (National Diagnostics) was
used for mounting slides. Images were captured using a Zeiss Axi-
oplan microscope and Zeiss Axiovision software.
Embryos for cryoembedding were processed through 7.5% and
15% sucrose then frozen in OCT embedding matrix (CellPath).
10 lm sections were cut and processed for immunoﬂuorescence.
Primary antibodies were diluted in 2% fetal bovine serum and incu-
bated with the sections overnight at 4 C. Anti-VE-Cadherin was
obtained from BD Pharmingen and anti-Prox1 from Reliatech.
Slides were then incubated at room temperature for one hour with
Fig. 2. Isl1Cre labels cells in the extra-embryonic vasculature. Isl1Cre expressing cells are labeled blue in each case. (A) At E9.5, the allantois expresses Isl1Cre (white arrow).
(B–D) From E11.5 onwards, the umbilical cord is b-galactosidase stained in Isl1Cre;ROSA26R embryos (black arrows), as is the interface of the umbilical cord with the placenta
(green arrows). In contrast, the yolk sac is not stained at any stages examined (red arrows). (E,F) Sections show that the entire umbilical cord (⁄) is derived from the Isl1Cre-
labelled lineage, including the endothelium of the vessels (arrows).There is no staining within the placenta (pl). Scale bar: A,D = 300 lm, B,C = 800 lm, E = 50 lm, F = 400 lm.
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2% fetal bovine serum. Anti-chicken Alexa 488 ﬂuor-conjugated,
anti-rat Alexa 546 ﬂuor-conjugated and anti-rabbit Alexa 594
ﬂuor-conjugated secondary antibodies were obtained from Life
Technologies. Slides were mounted in Vectashield with DAPI (Vec-
tor Laboratories) and images were captured using a Zeiss Axioim-
ager microscope with ﬁlters for DAPI, GFP, and Texas red and
with Zeiss Axiovision software.
Experiments using either parafﬁn wax sections or frozen sec-
tions included a negative control in which primary antibody was
absent; each experiment was repeated a minimum of three times.
2.4. Haemotoxylin and eosin staining
Staining was performed on paraformaldehyde-ﬁxed, parafﬁn
embedded tissue sections using standard protocols [13]. Sections
were cleared in Histoclear (National Diagnostics) then hydrated
in an ethanol gradient, stained in haemotoxylin, de-stained in acid
alcohol (1% HCl + 70% ethanol) and stained in 1% aqueous eosin.
Sections were then dehydrated in an ethanol gradient, cleared in
Histoclear and mounted in Histomount (National Diagnostics).
Images were captured using a Zeiss Axioplan microscope and Zeiss
Axiovision software.3. Results
3.1. Cells derived from an Isl1-expressing lineage contribute to the
vascular endothelium of systemic and umbilical vessels
Analysis of Isl1Cre;ROSA26R expression in embryos at E8.5
revealed labelled cells within the pharyngeal region and heart,
and in streams of cells extending towards the posterior part of
the embryo that are potentially associated with the dorsal aortae
(Fig. 1A). This led us to ask if cells derived from an Isl1-expressing
lineage might contribute more widely to the cardiovascular system
than has previously been reported.
At E8.5–E11.5, Isl1Cre based lineage tracing revealed labelled
cells within the endothelium of the aortic arch arteries, dorsal aor-
tae and the cardinal veins in the pharyngeal region (Fig. 1B, C and
Supplementary Fig. 1). These were found as individual or small
groups of cells around the entire circumference of the vessels,
co-expressing vascular endothelial (VE)-cadherin, an endothelial-
speciﬁc marker (Fig. 1D and Supplementary Fig. 2A–C). Isl1Cre-
labelled cells were also found in the posterior aorta at the level
of the hindgut (Fig. 1E) and were maintained in the endothelium
of the aorta, and jugular and caval veins, at E15.5 (Fig. 1 F,G). Isl1
protein was not found in the endothelium of the vessels at any
Fig. 3. Defects in the umbilical vasculature and in blood-lymph separation in Rac1ﬂox/ﬂox;Isl1Cre embryos. (A–C) Oedema (black arrows), blood stasis (red arrows) and
umbilical haemorrhage (blue arrow) are observed in Rac1ﬂox/ﬂox;Isl1Cre embryos but not their control littermates, at E14.5. (D,E) Engorgement and haemorrhage is observed in
the sectioned umbilical cord of mutant embryos (blue arrows). (F) Table showing incidence of defects in Rac1ﬂox/ﬂox;Isl1Cre embryos compared to controls. (G–I) In control
embryos, the jugular vein (j) and lymph sacs (⁄) are separate structures (G). In contrast, these are closer together than in controls (H), or fail to separate at all, in Rac1ﬂox/
ﬂox;Isl1Cre embryos (I). Scale bar: A–C = 1300 lm, D,E = 450 lm, G–I = 400 lm.
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expressing lineage contribute to the systemic vasculature of the
embryo, although Isl1 protein levels are down-regulated as the
progenitors differentiate into endothelial cells. Thus, as in the
endocardium of the heart [1], Isl1 protein is not expressed in differ-
entiated endothelial cells, and thus the Isl1Cre-labelled cells in the
vascular endothelium must reﬂect the earlier expression of Isl1 by
undifferentiated endothelial progenitors.
In view of this unexpected extra-cardiac vascular contribution,
we extended our analysis to include extra-embryonic tissues. At
E8.5-E9.5, Isl1Cre labelled cells were found within the allantois
(Fig. 2A), the precursor of the umbilical cord. From E10.5 onwards,
the entire umbilical cord, including the endothelial cells lining the
vessels, was labelled by Isl1Cre (Fig. 2B–F). However, the Isl1Cre-
expressing cells extended only minimally into the placenta
(Fig. 2D and F) and were not detected in the yolk sac vasculature
at any stages examined (Fig. 2B and C).
3.2. Conditional deletion of Rac1 using Isl1Cre results in vascular
defects
We asked whether the additional expression domains that we
describe might be developmentally important. We therefore
sought to delete Rac1 in the Isl1Cre-expressing lineage, as it has
been shown to be important for the formation of all three germ
layers of the embryo [14], including the vasculature [15,16], andthus might give us insight into the relevance of the Isl1-expressing
lineage in the vasculature.
Rac1ﬂox/ﬂox;Isl1Cre mutants died by E15.5 of gestation, with
severe cardiac malformations affecting both the inﬂow and outﬂow
regions of the heart. These defects are characteristic of those
observed when the contribution of cells from the second heart ﬁeld
is disrupted and will be described in detail elsewhere. However,
other malformations, not previously reported using Isl1Cre as a dri-
ver, were also observed (Fig. 3A–C). By E14.5, the umbilicus of Rac1-
ﬂox/ﬂox;Isl1Cre embryos showed engorgementwith blood (blue arrow
in Fig. 3B). Sectioning through the umbilical cord revealed massive
distension of the vessel and haemorrhage in Rac1ﬂox/ﬂox;Isl1Cre em-
bryos (Fig. 3D and E). Oedema (black arrows in Fig. 3B) and large
patches of blood, located in the upper trunk and less commonly in
the lower trunk close to the hind limb buds (red arrows in Figs. 3B
and C), were apparent in >50% of Rac1ﬂox/ﬂox;Isl1Cre embryos (10/
18 examined at E13.5–E14.5; Fig. 3F). This distribution of vascular
stasis appeared to be in the region where lymph sac separation oc-
curs [17], a process that is dependent onRac1 function [16]. Analysis
of Rac1ﬂox/ﬂox;Isl1Cremutants at E10.5–E15.5 revealed that the aorta,
and cardinal veins were well formed, as they were in Rac1ﬂox/ﬂox;-
Tie1Cremutants [16], with normal contributions of Isl1Cre-express-
ing cells to the endothelium of the vessels (Supplementary Fig. 2D
and E). However, marked abnormalities in the developing lymph
sacs were apparent. In all controls and in 8/18 Rac1
ﬂox/ﬂox
;Isl1Cremu-
tants, the jugular vein and jugular lymph sac had separated. How-
1794 I.D. Keenan et al. / FEBS Letters 586 (2012) 1790–1794ever, in 10/18 Rac1ﬂox/ﬂox;Isl1Cre mutants, the jugular veins and
lymph sacs had not separated, with accumulation of large numbers
of blood cells in the distended, common vessels (Fig. 3G–I). These
data support the idea that Rac1 plays essential roles in blood-lymph
separation [16] and suggest that cells derived from an Isl1-express-
ing lineage are crucial for this. Interestingly, prospero homeobox 1
(Prox1), a marker for lymphatic precursors, was not expressed by
Isl1Cre-positive cells and Isl1Cre-expressing cells were not found
in the lymph sacs at any stage of development (Supplementary
Fig. 3A–C). Thus, the cells derived from the Isl1-expressing lineage
play an indirect role in lymphangiogenesis, perhaps inducing the
expression of paracrine factors that inﬂuence neighbouring cells
to form lymphatic precursors. Analysis of Rac1ﬂox/ﬂox;Mef2c-AHFCre
(myocyte enhancer 2-anterior heart ﬁeld) mutants, in which Rac1
is deleted in the splanchnic and pharyngeal mesoderm of the ante-
rior second heart ﬁeld [7] did not show blood pooling characteristic
of abnormalities in blood-lymph separation (Supplementary Fig. 4A
and B). Normal separation of the blood and lymphatic systems was
conﬁrmed by sectioning of the embryos (Supplementary Fig. 4C and
D). Thus, the defects in blood-lymph separationwere not a non-spe-
ciﬁc consequence of deletion of Rac1 in the second heart ﬁeld, but
were speciﬁc to the Isl1-expressing lineage.
4. Discussion
This study, for the ﬁrst time, shows a direct contribution of Isl1-
expressing precursor cells to the systemic and umbilical vascula-
ture. As in the endocardium of the heart [1], Isl1 protein is not found
in the vascular endothelium, showing that it must be expressed at
an early stage of endothelial precursor formation. Whether these
cells originate in the heart ﬁelds [1] or from the allantois [18] re-
mains unclear, although the former would seem more likely. We
demonstrate that physiologically relevant abnormalities can be
produced in these areas when Isl1Cre is used for tissue-speciﬁc gene
deletion. Unfortunately, Isl1 null mice die by E10.5 of severe heart
malformations [1], before blood lymph separation is underway,
precluding an analysis of this process in the absence of Isl1. How-
ever, in vitro studies showing that Isl1-expressing precursors can
give rise to cells that express endothelial markers [4,5] and the re-
port that transfection of Isl1 into adult mesenchymal stem cells or
endothelial cells enhanced their vasculogenic and angiogenic po-
tential, [19] supports the idea that Isl1may play an important phys-
iological role. The observation that cells differentiated from induced
pluripotent stem cells, reprogrammed from Isl1Cre-expressing
ﬁbroblasts, expressed markers of vascular and haematopoietic lin-
eages [20], again supports the idea that Isl1 plays a role in endothe-
lial development. Thus, our study gives important in vivo support
for these in vitro analyses. In addition to its value as a key marker
of progenitor cells with cardiovascular potential, Isl1Cre is an
important tool for the genetic dissection of gene pathways within
the second heart ﬁeld. Our studies suggest, however, that in analys-
ing the effects of Isl1Cre-driven knock out of genes, broader inspec-
tion of the embryo, incorporating the systemic, lymphatic and
umbilical vasculature, should be carried out.
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